http://www.rxpgnews.com/ Medical News and Information Thu, 21 Aug 2008 02:00:28 PST en-us http://www.rxpgnews.com/ramelteon/Ramelteon_shows_less_potential_to_foster_abuse_and_4370_4370.shtml Ramelteon As part of the effort to develop effective behavioral and medical sleep therapies, scientists consider the potential for dependence and abuse associated with prescription sleep drugs. This line of research has produced findings showing that a recently approved prescription sleep drug may spare users the potential for dependence and abuse found with other sleep aids. Laboratory studies of the effects of ramelteon suggest that the drug's targeting of the brain's melatonin receptors rather than its benzodiazepine receptors make its subjective side effects different from those of old and new sedative hypnotics. Mon, 05 Jun 2006 16:19:00 PST http://www.rxpgnews.com/ramelteon/Ramelteon_shows_less_potential_to_foster_abuse_and_4370_4370.shtml http://www.rxpgnews.com/ramelteon/Ramelteon_showed_significant_reduction_in_time_to__3898_3898.shtml Ramelteon Results of a sub-analysis from a Phase III clinical study showed that ROZEREMTM (ramelteon) significantly reduced time to fall asleep in adults with chronic insomnia and showed no evidence of rebound insomnia or withdrawal effects. The results were presented today at the 2006 Annual Meeting of the American Academy of Neurology. Mon, 03 Apr 2006 23:35:00 PST http://www.rxpgnews.com/ramelteon/Ramelteon_showed_significant_reduction_in_time_to__3898_3898.shtml http://www.rxpgnews.com/ramelteon/FDA_Approves_Ramelteon_the_First_No_Abuse_Drug_for_1914_1914.shtml Ramelteon Takeda Pharmaceuticals North America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ROZEREM(TM) (ramelteon) 8-mg tablets for the treatment of insomnia characterized by difficulty with sleep onset. The FDA approval allows physicians to prescribe ROZEREM for long-term use in adults. Sat, 23 Jul 2005 23:56:00 PST http://www.rxpgnews.com/ramelteon/FDA_Approves_Ramelteon_the_First_No_Abuse_Drug_for_1914_1914.shtml http://www.rxpgnews.com/ramelteon/FDA_approved_Ramelteon_1911_1911.shtml Ramelteon Takeda Pharmaceuticals North America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ROZEREMTM (ramelteon) 8-mg tablets for the treatment of insomnia characterized by difficulty with sleep onset. The FDA approval allows physicians to prescribe ROZEREM for long-term use in adults. Sat, 23 Jul 2005 18:12:00 PST http://www.rxpgnews.com/ramelteon/FDA_approved_Ramelteon_1911_1911.shtml